BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29183688)

  • 1. An exploratory investigation of brain-selective estrogen treatment in males using a mouse model of Alzheimer's disease.
    Tschiffely AE; Schuh RA; Prokai-Tatrai K; Ottinger MA; Prokai L
    Horm Behav; 2018 Feb; 98():16-21. PubMed ID: 29183688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative evaluation of treatments with 17β-estradiol and its brain-selective prodrug in a double-transgenic mouse model of Alzheimer's disease.
    Tschiffely AE; Schuh RA; Prokai-Tatrai K; Prokai L; Ottinger MA
    Horm Behav; 2016 Jul; 83():39-44. PubMed ID: 27210479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with a brain-selective prodrug of 17β-estradiol improves cognitive function in Alzheimer's disease mice by regulating klf5-NF-κB pathway.
    Yan W; Wu J; Song B; Luo Q; Xu Y
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jul; 392(7):879-886. PubMed ID: 30879099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease.
    Amtul Z; Wang L; Westaway D; Rozmahel RF
    Neuroscience; 2010 Aug; 169(2):781-6. PubMed ID: 20493928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation.
    Heikkinen T; Kalesnykas G; Rissanen A; Tapiola T; Iivonen S; Wang J; Chaudhuri J; Tanila H; Miettinen R; Puoliväli J
    Exp Neurol; 2004 May; 187(1):105-17. PubMed ID: 15081593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prodrug DHED selectively delivers 17β-estradiol to the brain for treating estrogen-responsive disorders.
    Prokai L; Nguyen V; Szarka S; Garg P; Sabnis G; Bimonte-Nelson HA; McLaughlin KJ; Talboom JS; Conrad CD; Shughrue PJ; Gould TD; Brodie A; Merchenthaler I; Koulen P; Prokai-Tatrai K
    Sci Transl Med; 2015 Jul; 7(297):297ra113. PubMed ID: 26203081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
    J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease.
    Edwards SR; Hamlin AS; Marks N; Coulson EJ; Smith MT
    Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):798-806. PubMed ID: 25115283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Cardiotrophin-1 on Early Synaptic Mitochondrial Dysfunction and Synaptic Pathology in APPswe/PS1dE9 Mice.
    Wang D; Liu X; Liu Y; Li S; Wang C
    J Alzheimers Dis; 2017; 59(4):1255-1267. PubMed ID: 28731433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen therapy fails to alter amyloid deposition in the PDAPP model of Alzheimer's disease.
    Green PS; Bales K; Paul S; Bu G
    Endocrinology; 2005 Jun; 146(6):2774-81. PubMed ID: 15731362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
    Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A detailed analysis of the early context extinction deficits seen in APPswe/PS1dE9 female mice and their relevance to preclinical Alzheimer's disease.
    Bonardi C; de Pulford F; Jennings D; Pardon MC
    Behav Brain Res; 2011 Sep; 222(1):89-97. PubMed ID: 21440575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiotrophin-1 (CTF1) ameliorates glucose-uptake defects and improves memory and learning deficits in a transgenic mouse model of Alzheimer's disease.
    Wang D; Li X; Gao K; Lu D; Zhang X; Ma C; Ye F; Zhang L
    Pharmacol Biochem Behav; 2013 Jun; 107():48-57. PubMed ID: 23541490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
    PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin ameliorates insulin signalling pathway in brain of Alzheimer's disease transgenic mice.
    Feng HL; Dang HZ; Fan H; Chen XP; Rao YX; Ren Y; Yang JD; Shi J; Wang PW; Tian JZ
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):734-741. PubMed ID: 27466310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
    Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M
    Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mithramycin A Alleviates Cognitive Deficits and Reduces Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease.
    Wei C; Zhang W; Zhou Q; Zhao C; Du Y; Yan Q; Li Z; Miao J
    Neurochem Res; 2016 Aug; 41(8):1924-38. PubMed ID: 27072684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
    Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
    Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.